A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s diseaseStephen Salloway, Paul Aisen, Tammie L.S. Benzinger et al.|Nature Medicine|2021Cited by 364
Intrinsic capacity and its associations with incident dependence and mortality in 10/66 Dementia Research Group studies in Latin America, India, and China: A population-based cohort studyMartin Prince, Adolfo Valhuerdi, Yueqin Huang et al.|PLoS Medicine|2021Cited by 130
Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based studyJorge J. Llibre‐Guerra, Juan J. Llibre Rodríguez, Juan Carlos Llíbre-Guerra et al.|The Lancet Regional Health - Americas|2021Cited by 42
Amyloid‐Related Imaging Abnormalities in the <scp>DIAN‐TU</scp>‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph‐Mathurin, Richard J. Perrin, Neelum T. Aggarwal et al.|Annals of Neurology|2022Cited by 42
The impact of COVID-19 on the well-being and cognition of older adults living in the United States and Latin AmericaGanesh M. Babulal, Clara Vila‐Castelar, Ana Baena et al.|EClinicalMedicine|2021Cited by 40